Finally, in 2014, the G17V somatic mutation of the RhoA gene (Ras-homolog family member A) was described as a molecular biomarker of AITL, being found in up to 60-70% of MTCL cases with TFH-phenotype (24, 25). Here, RHOA is linked to angioimmunoblastic T-cell lymphoma.